Medtronic Inc. (NYSE:MDT) agreed to acquire Italian cardiovascular device maker Invatec and a pair of its affiliates for up to $500 million.
The Minneapolis-based medical device monolith said it will buy Invatec, which makes stents, angioplasty balloons and accessories, along with Fogazzi, Invatec’s corporate predecessor, and Krauth Cardiovascular, which distributes Invatec products in Germany.